gvtcx

Cytokine Modulators

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Statuscomplete
Category (CPV) 33600000
RegionScotland
Procedureopen
OCIDocds-h6vhtk-02923c

Awards (13)

This procurement was awarded to 12 suppliers. Values shown are per-award; the notice total is ·.

SupplierValueDateStatus
AbbVie Ltd shared · · active
Accord UK Ltd shared · · ·
Accord-UK Ltd shared · · ·
amgen ltd shared · · active
Biogen Idec Ltd. shared · · ·
Celltrion Healthcare United Kingdom Limited shared · · active
Fresenius Kabi Limited shared · · active
medac Pharma LLP shared · · ·
Merck Sharp & Dohme shared · · ·
Nordic Pharma Ltd shared · · ·
Pfizer Ltd shared · · ·
Sandoz Ltd shared · · active
not named · · unsuccessful

description

Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications.

Etanercept

Infliximab

Adalimumab

Methotrexate

The Goods have been split into eight (8) categories, each of which are identified as a “Lot”. Full details of each Lot are contained in section II.2 of this notice.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
11 Feb 2021 Contract award notice (F03) Earlier regulations 002773-2021

more from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Public Contracts Scotland. Contact details for named individuals are not reproduced on this site.